# Zadaxin and HIV-positive Patients With Immune Reconstitution Disorder

> **NCT04963712** · EARLY_PHASE1 · COMPLETED · sponsor: **Shanghai Public Health Clinical Center** · enrollment: 20 (actual)

## Conditions studied

- HIV-1-infection

## Interventions

- **DRUG:** Zadaxin

## Key facts

- **NCT ID:** NCT04963712
- **Lead sponsor:** Shanghai Public Health Clinical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-01
- **Primary completion:** 2022-07-22
- **Final completion:** 2022-08-11
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2023-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04963712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04963712, "Zadaxin and HIV-positive Patients With Immune Reconstitution Disorder". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT04963712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*